Characteristics and outcomes of venous thromboembolism in patients with hereditary hemorrhagic telangiectasia

Thromb Res. 2018 Sep:169:41-43. doi: 10.1016/j.thromres.2018.07.004. Epub 2018 Jul 4.

Authors

Shruti Chaturvedi¹, Rahil Kohli², Nicole Schaefer³, Marianne Clancy³, Raj S Kasthuri⁴

Affiliations

¹ Division of Hematology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA. Electronic address: [email protected].
² Medical University of the Americas, Saint Kitts and Nevis.
³ Cure HHT, Monkton, MD, USA.
⁴ Division of Hematology and Oncology, University of North Carolina, Chapel Hill, NC, USA.

PMID: 30015226
DOI: 10.1016/j.thromres.2018.07.004

No abstract available

Publication types

Letter

MeSH terms

Adult
Anticoagulants / therapeutic use
Blood Transfusion
Female
Humans
Iron / therapeutic use
Male
Middle Aged
Telangiectasia, Hereditary Hemorrhagic / complications*
Telangiectasia, Hereditary Hemorrhagic / therapy
Treatment Outcome
Venous Thromboembolism / complications*
Venous Thromboembolism / therapy

Substances

Anticoagulants
Iron